Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Recap: Nikkei +0.33%, Hang Seng (0.44%), Shanghai Composite (0.41%) as of 04:10 ET

Sep 17 ,2026

  • Synopsis:

    • Asian equities mixed Thursday. Semis contributed to Taiwan's outperformance. Japan, Australia and Singapore all ended higher. Greater China markets fell. India picking up mild gains. US futures rising. Treasury yields lower across tenors. Dollar strongest against Korean won. Yen strengthening somewhat from selloff overnight as attention shifts to BOJ. Oil lower on signs that supply disruptions could ease soon. Gold and silver lower. Bitcoin seeing mild gains.

    • Asian markets largely held their ground following much-anticipated FOMC meeting that delivered its first rate hike in more than three years and most officials penciled in one more hike by year end. Bonds stabilized as Treasuries rose along the curve after hawkish-leaning remarks to tame inflation from Chair Warsh that calmed markets. Among various initial takeaways, Warsh's emphasis on fighting inflation was seen easing concerns about his credibility that grew in aftermath of June's meeting. Press also highlighted how the Fed's rate hike raises stakes for Asia's central banks to follow suit, given currency and rate gap dynamic. BOJ widely expected to tighten on Friday with yen seen at risk if rate hike isn't accompanied by hawkish messaging.

    • Oil pullback, as Brent futures saw first back-to-back losses this month, attributed to some easing of concerns about Middle East supply following reports Saudi Arabia increasing crude flows via Hormuz and aiming to restore 50% of East-West pipeline capacity within days. Press also highlighted Houthi assurances of freedom of navigation in Red Sea to non-Saudi ships, and Trump planning post-war talks with Gulf leaders next week. In regional developments, New Zealand GDP growth moderated by less than forecast with living costs weighing on consumption. Singapore export growth accelerated in August, driven by a 132% surge in electronics exports amid booming AI-related demand. Japan PM Takaichi made few changes in her cabinet reshuffle, retaining almost all core members. FT reported EU has asked China to voluntarily restrict exports of hybrid vehicles or face higher tariffs.

    • In corporate news, SK Hynix (000660.KS) said company is exploring options to boost global competitiveness, and nothing has been finalized as it responded to report of Intel tie-up. Mitsubishi Heavy Industries (7011.JP) signed deal with AI startup Preferred Networks to develop AI technologies for defense equipment. Hanwha Systems (272210.KS) signed deal with UAE's EDGE Group to expand cooperation on integrated air defense systems. Z.AI (2513.HK) upgraded ARR guidance by almost 25% following recent $5B capital raising. Huawei (+HUAWEI) unveiled next-gen AI chips, CPUs and high-speed connectivity chips at its conference in Shanghai.

  • Digest:

    • Notable Gainers:

      • +12.6% 272210.KS (Hanwha Systems): signs term sheet with EDGE Group for integrated air defense system; explores the potential establishment of a JV in the UAE

      • +4% 7011.JP (Mitsubishi Heavy Industries): signs a capital and business alliance with AI startup Preferred Networks, in which the two will jointly develop domestic AI technologies for defense equipment and other systems

      • +3.3% 4568.JP (Daiichi Sankyo): Japan approves Daiichi Sankyo and AstraZeneca's Enhertu and Datroway for metastatic breast cancer

      • +2.8% 2513.HK (Z.AI): raises FY ARR guidance from $2.40B to $3.00B (CNY20.13B)

      • +2.8% 226950.KS (OliX Pharmaceuticals): submits plan to Australia's Bellberry Human Research Ethics Committee for phase IIa trial of OLX10212 for bilateral age-related macular degeneration with geographic atrophy

      • +1.9% 6501.JP (Hitachi): enters strategic partnership with Mission Critical Group to accelerate development/expansion of data center solutions

      • +1.7% 4502.JP (Takeda Pharmaceutical): receives approval from Japan's MHLW for marketing of ELAHERE for FRα-positive PROC

      • +0.6% 2344.TT (Winbond Electronics): Infineon Technologies to sell NOR Flash and F-RAM business to Winbond in all-cash transaction valued at $1.12B

    • Notable Decliners:

      • -2.2% 3037.TT (Unimicron Technology): plans to increase its ABF capacity by 30-40% in 2027

      • -1% 353200.KS (Daeduck Electronics Co.): reportedly to supply space-and-aviation-grade MLBs to Amazon by the end of the year

      • -0.4% 7201.JP (Nissan Motor): will produce the new Kicks hybrid SUV at its UK plant with an investment of £170M ($228M)

      • -0.09% 4689.JP (LY Corp.): LY, Bain raise Kakaku.com tender offer to ¥3,597/share, or ¥3,720/share with KDDI deal

  • Data:

    • Economic:

      • New Zealand

        • Q2 GDP +0.2% q/q vs consensus +0.1% and revised +0.8% in Q1

          • GDP +2.6% y/y vs consensus +2.2% and +1.5% in Q1

      • Singapore

        • August Non-Oil Export +46.2% y/y versus revised +24.1% in prior month

    • Markets:

      • Nikkei: 213.25 or +0.33% to 64136.25

      • Hang Seng: (109.49) or (0.44%) to 24604.29

      • Shanghai Composite: (16.00) or (0.41%) to 3875.60

      • Shenzhen Composite: (5.09) or (0.21%) to 2471.39

      • ASX200: 35.90 or +0.41% to 8732.40

      • KOSPI: (2.56) or (0.04%) to 6715.41

      • SENSEX: 173.19 or +0.23% to 74509.64

    • Currencies:

      • $-¥: (0.46) or (0.30%) to 155.8210

      • $-KRW: +7.46 or +0.54% to 1384.7090

      • A$-$: +0.00 or +0.38% to 0.7113

      • $-INR: (0.23) or (0.24%) to 95.9052

      • $-CNY: (0.00) or (0.02%) to 6.7067

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.